Salmonella enterica as a vaccine carrier
|Hegazy, Wael Abdel Halim
|DENDRITIC CELLS; DNA vaccine; EXPRESSION PLASMIDS; III SECRETION SYSTEM; IMMUNE-RESPONSES; intracellular pathogen; live attenuated bacteria; Microbiology; ORAL DNA VACCINATION; PATHOGENICITY ISLANDS; PROTECTIVE IMMUNITY; RECOMBINANT SALMONELLA; recombinant vaccine; SEROVAR TYPHIMURIUM; TUMOR-TARGETING SALMONELLA; type III secretion system
|FUTURE MEDICINE LTD
Salmonella enterica is an invasive, facultative intracellular gastrointestinal pathogen causing human diseases such as gastroenteritis and typhoid fever. Virulence-attenuated strains of this pathogen have interesting capacities for the generation of live vaccines. Attenuated live typhoidal and nontyphoidal Salmonella strains can be used for vaccination against Salmonella infections and to target tumor tissue. Such strains may also serve as live carriers for the development of vaccination strategies against other bacterial, viral or parasitic pathogens. Various strategies have been developed to deploy regulatory circuits and protein secretion systems for efficient expression and delivery of foreign antigens by Salmonella carrier strains. One prominent example is the use of type III secretion systems to translocate recombinant antigens into antigen presenting cells. In this review, we will describe the recent developments in strategies that utilize live attenuated Salmonella as vaccine carriers for prophylactic vaccination against infectious diseases and therapeutic vaccination against tumors. Considerations for generating safe, attenuated carrier strains, designing stable expression systems and the use of adjuvants for live carrier strategies are discussed.
Show full item record